Aralez Pharmaceuticals Stock Return On Equity
Aralez Pharmaceuticals fundamentals help investors to digest information that contributes to Aralez Pharmaceuticals' financial success or failures. It also enables traders to predict the movement of Aralez Stock. The fundamental analysis module provides a way to measure Aralez Pharmaceuticals' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Aralez Pharmaceuticals stock.
Aralez |
Aralez Pharmaceuticals Company Return On Equity Analysis
Aralez Pharmaceuticals' Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Current Aralez Pharmaceuticals Return On Equity | -262.08 |
Most of Aralez Pharmaceuticals' fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Aralez Pharmaceuticals is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
CompetitionBased on the latest financial disclosure, Aralez Pharmaceuticals has a Return On Equity of -262.08. This is much higher than that of the sector and notably lower than that of the Return On Equity industry. The return on equity for all United States stocks is notably higher than that of the company.
Aralez Return On Equity Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Aralez Pharmaceuticals' direct or indirect competition against its Return On Equity to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Aralez Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Aralez Pharmaceuticals by comparing valuation metrics of similar companies.Aralez Pharmaceuticals is currently under evaluation in return on equity category among related companies.
Aralez Fundamentals
| Return On Equity | -262.08 | |||
| Return On Asset | -6.75 | |||
| Profit Margin | (99.50) % | |||
| Operating Margin | (45.33) % | |||
| Current Valuation | 233.57 M | |||
| Shares Outstanding | 67.19 M | |||
| Shares Owned By Insiders | 9.58 % | |||
| Shares Owned By Institutions | 8.27 % | |||
| Number Of Shares Shorted | 2.97 M | |||
| Price To Earning | (0.85) X | |||
| Price To Book | 2.21 X | |||
| Price To Sales | 0.15 X | |||
| Revenue | 118.06 M | |||
| Gross Profit | 92.44 M | |||
| EBITDA | (17.23 M) | |||
| Net Income | (117.47 M) | |||
| Cash And Equivalents | 43.89 M | |||
| Cash Per Share | 0.65 X | |||
| Total Debt | 274.57 M | |||
| Current Ratio | 0.80 X | |||
| Book Value Per Share | (0.10) X | |||
| Cash Flow From Operations | (20.7 M) | |||
| Short Ratio | 2.14 X | |||
| Earnings Per Share | (1.76) X | |||
| Number Of Employees | 164 | |||
| Beta | 0.88 | |||
| Market Capitalization | 17.93 M | |||
| Total Asset | 32.26 M | |||
| Retained Earnings | (134.69 M) | |||
| Working Capital | 15.52 M | |||
| Current Asset | 32.01 M | |||
| Current Liabilities | 16.49 M | |||
| Z Score | -2.6 |
Pair Trading with Aralez Pharmaceuticals
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Aralez Pharmaceuticals position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Aralez Pharmaceuticals will appreciate offsetting losses from the drop in the long position's value.The ability to find closely correlated positions to International Flavors could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace International Flavors when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back International Flavors - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling International Flavors Fragrances to buy it.
The correlation of International Flavors is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as International Flavors moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if International Flavors moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for International Flavors can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of economic analysis. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.
Other Consideration for investing in Aralez Stock
If you are still planning to invest in Aralez Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Aralez Pharmaceuticals' history and understand the potential risks before investing.
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| CEOs Directory Screen CEOs from public companies around the world |